Read this in The Times in the UK with excitement, and then alarm. https://www.thetimes.co.uk/edition/news/common-diabetes-drug-may-be-treatment-for-parkinson-s-disease-xhz3cvtzx
Forgive me if I am loose on the details - but I read here that University College of London are about to launch a phase III trial into Parkinson's Disease using Exenitide.
I believe Exenitide is the same drug IXC are re-purposing for IIH. Is this correct?
If so, I thought we had global patent over it's use for several purposes not just IIH?
I assume IXC is playing no role in this study?
- Forums
- ASX - By Stock
- Parkinsons
Read this in The Times in the UK with excitement, and then...
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IXC (ASX) to my watchlist
|
|||||
Last
7.2¢ |
Change
0.002(2.86%) |
Mkt cap ! $5.411M |
Open | High | Low | Value | Volume |
7.0¢ | 7.2¢ | 6.6¢ | $3.476K | 50.58K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 29320 | 7.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
7.5¢ | 8695 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 29320 | 0.070 |
1 | 100000 | 0.066 |
1 | 100000 | 0.065 |
1 | 84879 | 0.063 |
2 | 158500 | 0.060 |
Price($) | Vol. | No. |
---|---|---|
0.075 | 8695 | 1 |
0.080 | 5000 | 1 |
0.090 | 126146 | 1 |
0.095 | 100000 | 1 |
0.100 | 8505 | 2 |
Last trade - 13.58pm 23/08/2024 (20 minute delay) ? |
IXC (ASX) Chart |
The Watchlist
SER
STRATEGIC ENERGY RESOURCES LIMITED
David DeTata, Managing Director
David DeTata
Managing Director
SPONSORED BY The Market Online